Richard Ridinger is chairman of the board of directors of dsm-firmenich, the nutrition, health and beauty group, elected to the chair by shareholders at an extraordinary general meeting in October 2026. He has served on the board as an independent director since 2023 and also sits on the compensation committee.
Ridinger was chief executive of the Swiss life sciences manufacturer Lonza from 2012 until 2019, and earlier held senior roles at the specialty chemicals business Cognis and at Henkel. His executive and board career spans pharmaceuticals, home and personal care, and nutrition and health.
Facts compiled by Executive Moves from publicly available news and press releases on 21 October 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you Richard Ridinger?
This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.
Claim this profile →
